Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Macrogol in Komb. (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD6
Opportunity Score
Confidence: 60%
Complexity: low
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open-house model for non-exclusive pharmaceutical rebate agreements on Macrogol combinations (ATC A06AD65) by AOK Bayern. Eligible pharma companies can join anytime until 2028-06-03, with contracts running from 2026-08-01 to 2028-07-31. No selection or award criteria; any qualified company can participate. No estimated value provided.
Strengths
Documents available
Open procedure
Low complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Must be a pharmaceutical company (pharmazeutischer Unternehmer).
- Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submit signed contract and annex specifying the products.
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Identifier
DE811695320
Lots (1)
Non-exclusive rebate agreements for Macrogol combination products, open to all qualifying pharmaceutical companies. Contracts are identical and non-negotiable.
Procurement Details
Publication
14 Jun 2026
Deadline
03 Jun 2028, 10:00
Procedure
open
Contract
supplies
Language
DEU
Publication #
408607-2026
Classification
Performance: Germany
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: low
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation